Brandinium

Trademark search for:

SEVER PHARMA SOLUTIONS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2021-08-19 — Application filed
  • 2021-11-04 — Sn assigned for sect 66a appl from ib
  • 2021-11-08 — Application filed
  • 2021-11-12 — Application filed
  • 2022-05-23 — Assigned to examiner
  • 2022-05-30 — Final disposition recorded
  • 2022-05-31 — Office action issued
  • 2022-06-23 — Office action issued
  • 2022-06-23 — Office action issued
  • 2022-07-13 — Office action issued
  • 2022-09-08 — Teas/email correspondence entered
  • 2022-09-08 — Office action issued
  • 2022-09-08 — Correspondence received in law office
  • 2022-09-19 — Approved for pub - principal register
  • 2022-10-05 — Notification of notice of publication e-mailed
  • 2022-10-25 — Published for opposition
  • 2022-10-25 — Official gazette publication confirmation e-mailed
  • 2022-11-07 — Extension of time to oppose received
  • 2022-12-01 — Teas withdrawal of attorney received
  • 2022-12-01 — Withdrawal of attorney granted
  • 2022-12-02 — Attorney/dom.rep.revoked and/or appointed
  • 2022-12-02 — Teas change of correspondence received
  • 2022-12-02 — Teas revoke/app/change addr of atty/dom rep received
  • 2023-02-01 — Teas post publication amendment received
  • 2023-02-13 — Assigned to petition staff
  • 2023-02-13 — Post publication amendment - entered
  • 2023-02-21 — Office action issued
  • 2023-02-21 — Office action issued
  • 2023-02-22 — Opposition instituted no. 999999
  • 2023-03-21 — Office action issued
  • 2023-04-05 — Notification of possible opposition sent to ib
  • 2023-04-05 — Notification of possible opposition created, to be sent to ib
  • 2023-04-24 — Notification of possible opposition - processed by ib
  • 2023-10-21 — Change of name/address rec'd from ib
  • 2024-06-06 — Application abandoned
  • 2024-06-06 — Opposition sustained no. 999999
  • 2024-06-06 — Opposition terminated no. 999999
  • 2024-06-06 — Application abandoned
  • 2024-06-11 — Final status recorded
  • 2024-06-30 — Death of international registration
  • 2024-06-30 — Notification of effect of cancellation of intl reg e-mailed

Owner Information

Sever Pharma Solutions AB
SE
QPharma AB
SE

Correspondent

RICHARD E PARKE WISSING MILLER LLP
31 HUDSON YARDS 11TH FLOOR
INDUSTRIOUS AT HUDSON YARDS
NEW YORK, NY 10001

Filing Details

Filing Date:
2021-08-19
Status Date:
2024-06-11
Category:
Pharmaceuticals
Filing Year:
2021

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.